Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-25 @ 8:06 PM
Study NCT ID:
NCT00399035
Status:
COMPLETED
Last Update Posted:
2016-12-28
First Post:
2006-11-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-13
First Submit QC Date:
None
Study First Post Date:
2006-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-29
Results First Submit QC Date:
None
Results First Post Date:
2012-10-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-04-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-11-07
Last Update Post Date:
2016-12-28
Last Update Post Date Type:
ESTIMATED